Non-clinical considerations when referring patients for CAR T-cell therapy
Navigating the decision-making process for CAR T-cell therapy can be complex and
challenging process for many patients. In this video,
Dr Wendy Osborne and Dr Laura
Dunning discuss non-clinical barriers to treatment and highlight how collaborative
approaches between referring and treating physicians can support patients in making
informed treatment decisions.
April 2026 UKI-YES-0524
Adverse events should be reported.
For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). For IE, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead to [email protected] or +44(0) 1223 897500 or +353(0) 21 482 5999.